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Abstract 24 
The natural food for Atlantic salmon (Salmo salar) in freshwater has relatively lower levels 25 
of omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFA) than found in prey for 26 
post-smolt salmon in seawater. Land-locked salmon such as the Gullspång population feed 27 
exclusively on freshwater type lipids during its entire life cycle, a successful adaptation 28 
derived from divergent evolution. Studying land-locked populations may provide insights 29 
into the molecular and genetic control mechanisms that determine and regulate n-3 LC-PUFA 30 
biosynthesis and retention in Atlantic salmon. A two factorial study was performed 31 
comparing land-locked and farmed salmon parr fed diets formulated with fish or rapeseed oil 32 
for 8 weeks. The land-locked parr had higher capacity to synthesise n-3 LC-PUFA as 33 
indicated by higher expression and activity of desaturase and elongase enzymes. The data 34 
suggested that the land-locked salmon had reduced sensitivity to dietary fatty acid 35 
composition and that dietary docosahexaenoic acid (DHA) did not appear to suppress 36 
expression of LC-PUFA biosynthetic genes or activity of the biosynthesis pathway, probably 37 
an evolutionary adaptation to a natural diet lower in DHA. Increased biosynthetic activity did 38 
not translate to enhanced n-3 LC-PUFA contents in the flesh and diet was the only factor 39 
affecting this parameter. Additionally, high lipogenic and glycolytic potentials were found in 40 
land-locked salmon, together with decreased lipolysis which in turn could indicate increased 41 
use of carbohydrates as an energy source and a sparing of lipid. 42 
 43 
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1. Introduction 47 
Omega 3 (n-3) long chain polyunsaturated fatty acids (LC-PUFA), eicosapentaenoic acid 48 
(EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3), are essential dietary nutrients 49 
with well-known health benefits in humans [1]. Fish and seafood is the main dietary source of 50 
n-3 LC-PUFA for humans, with aquaculture providing close to half (47 %) of all the products 51 
on the market [2], although almost all commercially available Atlantic salmon (Salmo salar 52 
L.) is farmed. Feeds for farmed fish have traditionally relied on the use of fishmeal and fish 53 
oil derived from marine fisheries as the main protein and lipid sources. The resulting demand 54 
for marine resources is such that requirements for aquaculture feeds now exceed global 55 
supplies of fish oil [3]. Continued expansion of aquaculture to supply the global demand for 56 
fish is only possible by replacing fish oil and, currently the main sustainable alternatives are 57 
vegetable oils, which can be rich in C18 PUFA such as linoleic (LNA; 18:2n-6) and α-58 
linolenic (ALA; 18:3n-3) acids, but devoid of EPA and DHA [4]. Thus, fish fed diets 59 
formulated with vegetable oil are characterised by increased levels of C18 PUFA and 60 
decreased levels of n-3 LC-PUFA compared to fish fed fish oil, reducing their nutritional 61 
value to human consumers [5]. Therefore, flesh n-3 LC-PUFA content and composition is a 62 
key trait determining the nutritional quality of farmed salmon [6]. 63 
A recent study comparing 50 families from a salmon breeding programme fed vegetable oil 64 
showed high variability in flesh n-3 LC-PUFA levels, with the trait showing a high level of 65 
heritability estimated at h2 = 0.77 [7], indicating that the trait is affected by environment to 66 
only a very limited degree and that differences observed between populations have most 67 
likely a genetic origin. This demonstrated the potential of selective breeding to improve this 68 
trait, and has prompted a focus on the genetic architecture of LC-PUFA biosynthesis and 69 
metabolism in salmon. Recent studies have indicated that tissue fatty acid compositions are 70 
determined by the relative activities of a range of metabolic pathways including transport and 71 
uptake, oxidation and deposition, and endogenous biosynthesis [8-11]. However, precisely 72 
what the most critical pathways and genes in determining tissue LC-PUFA compositions are, 73 
and how diet interacts with and affects these molecular pathways are poorly understood in all 74 
animals, including salmon.  75 
Atlantic salmon start life in freshwater followed by smoltification and migration to the sea 76 
before they return to their native river to spawn [12]. However, after the last glacial period, 77 
some Atlantic salmon stocks were isolated from the sea in both North America and Europe 78 
4 
 
and these land-locked populations complete their life-cycle in freshwater, spending their adult 79 
life mainly in large lakes instead of the sea. This means that land-locked salmon are exposed 80 
to lower levels of EPA and DHA, during their lifespan than their anadromous counterparts, 81 
which asks the question of whether land-locked populations may have potentially higher 82 
capacity for LC-PUFA biosynthesis than anadromous populations [5,13]. In an earlier study, 83 
the fatty acid compositions of land-locked and farmed Atlantic salmon fed diets formulated 84 
with vegetable oils were compared [14]. The authors interpreted the data to suggest that land-85 
locked salmon may have a higher conversion capacity for n-3 and n-6 PUFA than 86 
anadromous counterparts, and that there was a genetic influence on DHA content in 87 
phospholipids [14]. This suggested that these wild populations could provide a highly 88 
valuable genetic resource for enhancing farmed Atlantic salmon stocks but, as few studies 89 
have assessed farmed and land-locked salmon populations in detail, they represent an under-90 
exploited resource.  91 
In this context, the overarching aim of this work was to characterise the n-3 LC-PUFA trait in 92 
land-locked salmon and to determine the molecular and biochemical basis for any differences 93 
observed in the trait between farmed and land-locked Atlantic salmon populations. To 94 
achieve this, a 2 x 2 factorial nutritional trial employing two feeds containing fish oil or 95 
vegetable oil as the added lipid were tested over 8 weeks in two populations of Atlantic 96 
salmon, the Norwegian national farmed stock of the Aquagen strain (F) and the Swedish 97 
Gullspång land-locked stock (W). Effects of dietary fatty acid composition on gene 98 
expression in liver by microarray (transcriptome) analysis, hepatocyte fatty n-3 LC-PUFA 99 
biosynthesis activities by incubation with radiolabelled 18:3n-3, and resultant muscle (flesh) 100 
fatty acid compositions were determined.  101 
 102 
2. Materials and methods 103 
2.1 Ethics statement 104 
All procedures and protocols were performed in accordance with Local (Institute of Marine 105 
Research), Norwegian national, and European (EU) Regulations for the use of animals in 106 
scientific experimentation (Directive 2010/63/EU). 107 
2.2 Dietary trial and sampling 108 
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Eggs were obtained from a land-locked Atlantic salmon population (Lake Vanern/Gullspång 109 
Swedish stock) and incubated and hatched in April 2013 at the facilities of the Institute of 110 
Marine Research (IMR) (Matre, Norway). Two isonitrogenous and isoenergetic feeds, 111 
formulated to satisfy the nutritional requirements of salmonid fish (NRC, 2011), were 112 
manufactured by the Norwegian Institute of Food, Fisheries and Aquaculture Research 113 
(Nofima Fôrteknologisenteret, Fana, Norway) by vacuum coating identical dry basal extruded 114 
pellets with either fish oil (FO) or rapeseed oil (RO) and were named according to the oils 115 
used (Table 1). The dietary fatty acid profiles reflected the oil source with the FO diet 116 
containing high levels of LC-PUFA (17.3 % vs. 7.8 % in RO), whereas the levels of 18:3n-3 117 
were higher in the RO diet than in the FO diet (6.0 % vs. 1.0 %) (Table 1). A classic factorial 118 
2 trial was performed comparing land-locked (termed W) and farmed (termed F, Aquagen 119 
strain) parr fed the two diets to produce four experimental treatments (WFO, WRO, FFO and 120 
FRO).  121 
Twelve 400 L tanks (1x1 m) were stocked with 50 parr (initial weight ~ 25 g) with 6 tanks of 122 
each population and the two experimental feeds were fed to triplicate tanks for 8 weeks until 123 
at least a doubling of weight (~ 60 g). At the end of the feeding trial, twelve fish per 124 
treatment (4 fish per replicate tank) were sampled and flesh (white muscle) collected in liquid 125 
nitrogen. In addition, liver of 12 fish was removed and divided into two portions. One portion 126 
(~100 mg) was stabilised in RNALater® for subsequent gene expression analyses, whereas 127 
the remaining portion was used to determine the hepatocyte fatty acyl desaturation and 128 
elongation activities. All fish were weighed at the end of the experimental period and specific 129 
growth rate (SGR) calculated as follows: SGR = 100 * (lnWf – lnWo)/t, where Wo = initial 130 
weight (g) and Wf = final weight (g) at time t (days). 131 
2.3 Determination of hepatocyte fatty acyl desaturation/elongation activities 132 
Each pool (per tank) of liver was chopped, incubated with 1 % collagenase, and dissociated 133 
cells sieved through 100 μm nylon gauze and isolated as described in detail previously [16]. 134 
One hundred μl of each cell preparation was taken for protein determination [17] following 135 
incubation with 1 M NaOH/0.25 % (w/v) SDS for 1 h at 60 °C. Five ml of each cell 136 
preparation were dispensed into 25 cm2 tissue culture flasks and incubated at 18 °C for 1 h 137 
with 0.25 μCi (final fatty acid concentration, 2 μM) of [1-14C]18:3n-3 added as a complex 138 
with fatty acid free-bovine serum albumin [18]. After incubation, cells were harvested, 139 
washed and cell total lipid extracted as described in detail previously [16]. Fatty acid methyl 140 
Table 1 
here 
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esters were prepared as described below, separated by argentation chromatography on silver 141 
nitrate-impregnated TLC plates, subjected to autoradiography, and radioactivity in individual 142 
fatty acids determined by liquid scintillation counting, all as described in detail previously 143 
[16]. 144 
2.4 Total lipid extraction 145 
Lipid was extracted from flesh samples using a modified method of Folch et al. [19]. 146 
Briefly, samples were homogenised in 16 ml of chloroform/methanol (2:1, v/v) using an 147 
Ultra-Turrax tissue disrupter (Fisher Scientific, Loughborough, UK). Non-lipid impurities 148 
were removed by washing with 4 ml of 0.88 % aqueous KCl (w/v) and the upper aqueous 149 
layer removed by aspiration, and the lower solvent layer containing the lipid extract dried 150 
under oxygen-free nitrogen. Total lipid content was determined gravimetrically after 151 
overnight desiccation in vacuo.  152 
 153 
2.5 Fatty acid composition 154 
Fatty acid methyl esters were prepared from 10 mg of total lipid by acid-catalysed 155 
transmethylation according to the method of Christie [19]. FAME were separated and 156 
quantified by gas-liquid chromatography using a Fisons GC-8160 (Thermo Scientific, 157 
Milan, Italy) equipped with a 30 m × 0.32 mm i.d. × 0.25 μm ZB-wax column 158 
(Phenomenex, Cheshire, UK), on-column injector and a flame ionisation detector. Hydrogen 159 
was used as the carrier gas in constant flow mode at 2.5 ml min-1, with an initial thermal 160 
gradient from 50 °C to 150 °C at 40 °C min−1 and to a final temperature of 230 °C at 2 °C 161 
min−1. Data were collected and processed using Chromcard for Windows (version 2.01; 162 
Thermoquest Italia S.p.A., Milan, Italy). Individual FAME were identified by comparison to 163 
known standards and published data [21-22]. Selected FAME were confirmed by gas 164 
chromatography-mass spectrometry (GC-MS) using a gas chromatograph (GC8000) 165 
coupled to a MD800 mass spectrometer (ThermoFisher Scientific, Hemel Hempstead, UK). 166 
 167 
2.6 RNA extraction 168 
Liver from twelve individual fish per dietary treatment were homogenised in 1 ml of 169 
TriReagent® (Sigma-Aldrich, Dorset, UK) RNA extraction buffer using a bead tissue 170 
disruptor (Bio Spec, Bartlesville, Oklahoma, USA). Total RNA was isolated following 171 
manufacturer’s instructions, purified using a commercial kit (RNeasy Mini Kit, Quiagen, 172 
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Manchester, UK) and quantity and quality determined by spectrophotometry using a 173 
Nanodrop ND-1000 (Labtech Int., East Sussex, UK) and electrophoresis using 500 ng of total 174 
RNA in a 1 % agarose gel. To perform the RNA amplifications, 2500 ng from two fish 175 
belonging from the same tank were pooled to obtain six samples per treatment and stock. 176 
2.7 Microarray hybridizations and image analysis 177 
Transcriptome analysis was performed in liver using an Atlantic salmon custom-made 178 
oligoarray with 44k features per array on a four-array-per-slide format (Agilent Technologies 179 
UK Ltd., Wokingham, UK), ArrayExpress accession number A-MEXP-2065. The probes 180 
were co-designed by researchers at the Institute of Aquaculture (University of Stirling, UK) 181 
and the Norwegian Institute of Food, Fisheries and Aquaculture Research (Nofima, Tromsø, 182 
Norway). A dual-label experimental design was employed for the microarray hybridisations 183 
with Cy3-labelled test samples competitively hybridised to a common Cy5-labelled pooled-184 
reference per array. A total of 24 arrays were utilised. The common reference was a pool of 185 
equal amounts of amplified RNA from all test samples.  186 
Indirect labelling methodology was employed in preparing the microarray targets. Amplified 187 
antisense RNA (aRNA) was produced from each RNA sample using TargetAmpTM 1-Round 188 
Aminoallyl-aRNA Amplification Kit 101 (Epicentre, Madison, Wisconsin, USA), as per 189 
manufacturer’s methodology, followed by Cy3 or Cy5 fluor incorporation through a dye-190 
coupling reaction. Briefly, 250 ng of total RNA per sample were amplified and column 191 
purified (RNeasy Mini Kit, Qiagen, Manchester, UK) according to manufacturer’s 192 
instructions. Resultant aRNA quantity and quality was assessed by spectrophotometry and 193 
electrophoresis as above. In addition, amino-allyl incorporation (ratio A289/A260) was 194 
determined. Experimental and the pooled reference samples were labelled with Cy3 and Cy5 195 
dye suspension respectively, (GE HealthCare, Little Chalfont, UK). To attach the Cy dyes, 196 
2.5 μg from each aRNA sample were suspended in 10.5 μl nuclease-free water and heated to 197 
75 ˚C for 5 min. When cooled, 3 μl of coupling buffer (0.5M NaOHCO3; pH 9.0) and 1.5 μl 198 
of Cy3 or 0.8 μl of Cy5 dye suspension were added as appropriate followed by incubation for 199 
1 h at 25 ˚C in the dark. Unincorporated dye was removed by column purification (Illustra 200 
AutoSeq G-50 spin columns, GE Healthcare). Dye incorporation and aRNA yield were 201 
quantified by spectrophotometry and further quality controlled by separating 0.4 μl of the 202 
sample through a 1 % agarose gel and products visualised on a fluorescence scanner 203 
(Typhoon Trio, GE Healthcare).  204 
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Microarray hybridisations were performed in SureHyb hybridisation chambers in a DNA 205 
Microarray Hybridisation Oven (Agilent Technologies). For each hybridisation, 825 ng of 206 
Cy3-labelled experimental biological replicate and Cy5-labelled reference pool were 207 
combined and total volume made up to 35 μl with nuclease-free water. A fragmentation 208 
master mix was prepared containing per reaction, 11 μl 10X Blocking agent, 2 μl 25X 209 
fragmentation buffer and 7 μl nuclease-free water and added to the Cy-dyes mix. After 210 
incubating in the dark at 60 ˚C for 30 min, 57 μl 2X GE Hybridisation buffer (pre-heated at 211 
37˚C) was added, contents gently mix, centrifuged at 20000 g for 1 min and kept on ice until 212 
loaded onto the microarray slides. Hybridisation was carried out in an oven rotator (Agilent 213 
Technologies) at 65 ˚C and 10 rpm for 17 h. Post-hybridisation washes were carried out in 214 
EasyDipTM Slide staining containers (Canemco Inc., Quebec, Canada). After disassembling 215 
the array-gasket sandwiches submersed in wash buffer 1 at room temperature, the microarray 216 
slides were transferred to an EasyDipTM container and incubated in wash buffer 1 for 1 min at 217 
150 rpm, and then a further 1 min at 31 ˚C at 150 rpm in wash buffer 2. A final dip in wash 218 
buffer 2 at room temperature was performed, after which the slides were dried and kept in the 219 
dark until scanned the same day. Scanning was performed at 5 μm resolution using an Axon 220 
GenePix 4200AL Scanner (MDS Analytical Technologies, Wokingham, Berkshire, UK). 221 
Laser power was kept constant (80 %) and PMT adjusted for each channel such than less than 222 
0.1 % features were saturated and that the mean intensity ratio of the Cy3 and Cy5 signals 223 
was close to one.  224 
2.8 Quantitative real time PCR 225 
Expression of candidate genes of interest (fatty acyl desaturases 5 and 6 and fatty acyl 226 
elongases 2, 5a and 5b) as well as genes for microarray validation (Supplementary Table 1) 227 
was determined by quantitative PCR (qPCR) in liver from fish of all treatments. Results were 228 
normalised using reference genes, elongation factor 1-α (ef1a) and cofilin-2 (cfl2), which 229 
were chosen as the most stable according to GeNorm. cDNA was synthesised using 2 μg of 230 
total RNA and random primers in 20 μl reactions and the High capacity reverse transcription 231 
kit without RNase inhibiter according to the manufacturer’s protocol (Applied Biosystems, 232 
Warrington, UK). The resulting cDNA was diluted 20-fold with milliQ water. Primers were 233 
designed using Primer 3 [23] in regions that included the microarray probes and efficiency 234 
evaluated by serial dilutions to ensure that it was close to 100 %. qPCR was performed using 235 
a Biometra TOptical Thermocycler (Analytik Jena, Goettingen, Germany) in 96-well plates 236 
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in duplicate 20 μl reaction volumes containing 10 μl of Luminaris Color HiGreen qPCR 237 
Master Mix (Thermo Scientific), 1 μl of the primer corresponding to the analysed gene (10 238 
pmol), 3 μl of molecular biology grade water and 5 μl of cDNA, with the exception of the 239 
reference genes, which were determined using 2 μl of cDNA. In addition amplifications were 240 
carried out with a systematic negative control (NTC-no template control) containing no 241 
cDNA. Standard amplification parameters contained an UDG pre-treatment at 50 °C for 2 242 
min, an initial activation step at 95 °C for 10 min, followed by 35 cycles: 15 s at 95 °C, 30 s 243 
at the annealing Tm and 30 s at 72 °C.  244 
2.9 Statistical analysis 245 
All data are means ± S.E. (n = 3) unless otherwise specified. Percentage data were subjected 246 
to arcsin square-root transformation prior to statistical analyses. Data were tested for 247 
normality and homogeneity of variances with Levene’s test prior to one-way analysis of 248 
variance followed by a Tukey-Kramer HSD multiple comparisons of means. All statistical 249 
analyses were performed using SPSS software (IBM SPSS Statistics 19; SPSS Inc., Chicago, 250 
IL, USA). Microarray hybridisation data were analysed in GeneSpring GX version 12.6.1 251 
(Agilent Technologies, Wokingham, Berkshire, UK) by two-way analysis of variance 252 
(ANOVA), which examined the explanatory power of the variables diet and population as 253 
well as “diet x population” interaction. No multiple test correction was employed as previous 254 
analyses indicated that they were over-conservative for these nutritional data [24]. Data were 255 
submitted to the Kyoto Encyclopedia of Genes and Genomes (KEGG) [25] for biological 256 
function analysis. Gene expression results were analysed using the relative expression 257 
software tool (REST 2009; http://www.gene-quantification.info/), which employs a pairwise 258 
fixed reallocation randomisation test (10,000 randomisations) with efficiency correction [26] 259 
to determine the statistical significance of expression ratios (gene expression fold changes) 260 
between two treatments. 261 
The relationship (if any) between hepatic expression of LC-PUFA biosynthesis-related genes 262 
and flesh PUFA profiles was explored by applying multivariate principal component analysis 263 
(PCA) using SPSS. Data included in the PCA analysis were log2 fold change of gene 264 
transcripts and the percentages of n-6 and n-3 PUFA. After performing PCA, components 265 
scores were clustered according to the Ward’s method followed by K-means cluster in order 266 
to quantitatively define the relationships observed in the PCA. 267 
3. Results 268 
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3.1 Fish performance 269 
Fish doubled their weight by the end of the dietary trial and survival was 100 % throughout 270 
the experimental period. No differences were observed in fish final weight among the dietary 271 
treatments or populations (Table 2). However, as the farmed stock fish had a higher initial 272 
weight this meant that the Gullspång land-locked population had a significantly higher 273 
specific growth rate (SGR) (Table 2). Two-way ANOVA highlighted that SGR was 274 
significantly affected by the population factor (p<0.001), and there was no interaction 275 
between population and dietary factors. The land-locked population also had a higher K-276 
factor at the end of trial (> 1.4) compared to the farmed strain (ca 1.3)  277 
3.2 Flesh lipid content and fatty acid profile 278 
Salmon fed the RO diet tended to display higher lipid deposition in muscle tissue, although 279 
no statistically significant differences were observed among the populations or dietary 280 
treatments (p = 0.174; Table 3). In general, fatty acid composition only varied according to 281 
the diet with population having no effect on the flesh fatty acid profile. Therefore, fish fed the 282 
FO diet reflected the dietary fatty acid composition with higher levels of n-3 LC-PUFA, 283 
particularly EPA, 22:5n-3 and DHA. Conversely, the RO-fed fish displayed a typical 284 
terrestrial-type fatty acid composition, with higher levels of total monoenes and n-6 PUFA. 285 
No differences were observed in flesh fatty acid compositions between land-locked and 286 
farmed salmon for each of the dietary treatments. Nevertheless, significant interactions 287 
between diet and population were observed for 20:4n-3 and 22:5n-3 levels in flesh. 288 
3.3. Activity of LC-PUFA biosynthesis pathway in hepatocytes 289 
The fatty acyl desaturation/elongation activities determined in hepatocytes at the end of the 290 
dietary trial using [1-14C]18:3n-3 as substrate showed significant differences between the 291 
populations and dietary treatments (Table 4). Thus, recovery of radioactivity in desaturated 292 
products was higher in land-locked salmon regardless of dietary treatment. The rank order for 293 
overall pathway activity (Total) and recovery of radioactivity in EPA and 22:5n-3 was WRO 294 
> WFO >FRO > FFO. Recovery of radioactivity in DHA was also highest in hepatocytes 295 
from WRO and over two-fold higher than the recovery of radioactivity in DHA in FRO. The 296 
recovery of radioactivity in the 20:3n-3 elongation product showed a reciprocal response to 297 
desaturated products with the rank order being FRO > FFO > WFO >WRO. Population had a 298 
more profound effect on desaturation activity than dietary treatment, being significant for all 299 
Table 2 
here 
Table 3 
here 
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the desaturated products (Table 4). Diet only significantly affected recovery of radioactivity 300 
in EPA and DHA and, similarly, these were the fatty acids where there was no interaction 301 
between population and diet.  302 
3.4 Expression of genes of LC-PUFA biosynthesis in liver 303 
Quantification of expression of fatty acyl desaturase and elongase genes involved in the 304 
biosynthesis of LC-PUFA showed there was a clear effect of population in fish fed the FO 305 
diet with higher expression of all genes, other than elovl5b, in land-locked salmon compared 306 
to the farmed stock (Fig.1). In contrast, there was no difference between the populations in 307 
the expression of the LC-PUFA genes when fed the RO diet, other than lower expression of 308 
elovl5b in the land-locked population. Diet had a clear effect on the expression of the LC-309 
PUFA biosynthesis genes in the farmed population with higher expression of all genes, 310 
significantly so in the case of the fads genes and elovl5b, in fish fed RO compared to fish fed 311 
FO (Fig.1). However, the opposite trend was apparent in the land-locked population with 312 
generally lower expression in fish fed the RO diet compared top fish fed the FO diet albeit 313 
this was only significant with elovl5b. 314 
3.5 Principal component analysis 315 
The application of PCA and algorithm clustering resulted in the segregation of three clear 316 
clusters in both the farmed and land-locked stocks (Fig. 2). PCA explained around 80 % of 317 
the total variation present in the data matrix in both populations with PC1 accounting for 318 
about 69 % and 62 % in farmed and land-locked populations, respectively. However, how the 319 
fatty acids and genes clustered was very different between the two salmon populations. In the 320 
farmed stock, PC1 clearly separated the n-6 PUFA, other than arachidonic acid (ARA, 20:4n-321 
6), from the n-3 PUFA with the main pathway products (ARA, EPA and DHA) also in a 322 
distinct cluster (Fig. 2A). All the fads and elovl genes clustered with the n-6 PUFA. In the 323 
land-locked population, PC1 still generally separated the n-6 and n-3 PUFA but in the 324 
opposite direction to that observed in the farmed population (Fig. 2B). Most genes of LC-325 
PUFA biosynthesis clustered with the main n-3 PUFA group other than fads2d6 that 326 
clustered separately with the main products in the n-6 and n-3 pathways, ARA and DHA 327 
(Fig. 2B).  328 
3.6 Responses of liver transcriptome 329 
Table 4 
here 
Fig. 1 
here 
Fig. 2 
here 
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A first approach to the analysis of the liver transcriptome dataset showed that that the 330 
normalised data grouped into two well differentiated clusters, with population (F and W) 331 
being the condition influencing the hierarchical clustering (Fig.3). Each population separated 332 
into subclusters reflecting dietary regime with two obvious clusters representing the FO and 333 
RO fed groups for the land-locked (W) salmon although this was not as clear in farmed (F) 334 
salmon where there was some overlap between the two dietary groups.  335 
Two-way ANOVA of the cDNA microarray dataset to identify differentially expressed genes 336 
and classify the observed expression patterns returned a high number of features showing 337 
evidence of differential expression (p < 0.05) for each factor. A total of 6889 probes were 338 
affected by population with a subset 3924 that were exclusively affected by population and 339 
not diet (Fig. 4A). Similarly, 6063 probes exhibited differential expression in response to 340 
diet, with 3089 probes only affected by diet, 2371 probes affected by both population and diet 341 
and 445 affected by diet and the interaction of diet and population (Fig. 4A). The lists for 342 
each comparison were subjected to further analysis by assigning KEGG orthology (KO) 343 
numbers and mapping them to a known compendium of categories (KEGG; excluding 39-40 344 
% non–annotated features). The functional categories most affected were the same when 345 
analysing effects of population, diet and interaction, with those being metabolism (mainly 346 
carbohydrate, amino acid, lipid and energy metabolism) followed by signalling and immune 347 
responses (Figs. 4B-D).  348 
To elucidate which pathways were affected by the genetic background of the fish, the list of 349 
genes exclusively affected by population (3924 probes) were KEGG-mapped and 350 
differentially expressed pathways evaluated. Figure 5 represents a chart where each pathway 351 
is represented by a bubble that is colour coded for functional category with the size of the 352 
bubble representing the number of differentially expressed genes (DEG) in each pathway. 353 
The main functional category affected was that of Environmental Information Processing, 354 
displaying 9 significantly affected pathways with a variable number of genes affected in each 355 
pathway (19-45 differentially expressed genes, DEG). Genetic Information displayed the 356 
highest number of DEG, particularly in ribosome (80 DEG), which also showed one of the 357 
lowest p values (p = 0.007). Similarly, the highest absolute fold change (FC) was found in 358 
two pathways belonging to the Genetic Information category (ubiquitin mediated proteolysis 359 
and protein processing in endoplasmic reticulum; FC = 2.02 and 1.95, respectively). 360 
Organismal System was also affected, displaying 8 different pathways with over 18 DEG in 361 
each. Within this category, two pathways intimately related to metabolism, insulin and 362 
Fig. 3 
here 
Fig. 4 
here 
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glucagon signalling, were affected. Regarding metabolism, only three pathways displayed 363 
over 18 DEG. Nucleotide metabolism was affected by population with purine and pyrimidine 364 
metabolism showing similar p values (0.013 and 0.014 respectively) albeit a higher absolute 365 
FC was found for pyrimidine (1.52 vs. 1.41).  366 
The metabolic category most affected by population was carbohydrate metabolism (157 367 
DEG) followed by lipid and amino acid metabolism (104 and 102 DEG, respectively; Fig. 368 
6A). In lipid metabolism, glycerophospholipid and ARA metabolism were highly affected, 369 
with highest up-regulated FC in phosphatidate phosphatase (ppap2, +5.30) and 370 
lysophosphatidic acid acyl transferase (agpat, +2.63; Supplementary Table 2). In addition, 371 
there was high representation of genes of fatty acid oxidation including carnitine palmitoyl 372 
transferase 2 (cpt2), 3-hydroxyacyl-CoA dehydrogenase (hoad) and acyl-coA oxidase (aco) 373 
that were all down-regulated in land-locked salmon (Supplementary Table 2). In contrast, 374 
lipogenic pathway genes including fatty acid synthase (fas), glucose 6-phosphate 375 
dehydrogenase (g6pd) and peroxisome proliferator-activated receptor gamma (pparg) were 376 
up-regulated in land-locked salmon regardless of diet (Supplementary Table 2). The top 10 377 
metabolic pathways, according to the number of DEG, showed that amino acid metabolism 378 
was the most represented category (4 pathways), followed by lipid and carbohydrate (three 379 
pathways each; Fig.6B). A positive correlation (R2 = 0.9715) was found between the 380 
metabolic functional categories, where high FC was correlated with high –log10 P values, 381 
indicating that highly significant genes also displayed high FC. This was particularly evident 382 
for the metabolic categories of energy, carbohydrate and lipid.  383 
Listing the top 100 genes according to significance, an overrepresentation of metabolic 384 
pathways was found (33 %) with carbohydrate and lipid metabolism being the most 385 
represented (8% each; Supplementary Table 3). Translation (18 %) and signal transduction 386 
(17 %) were the most affected categories after metabolism. Six percent of DEG belonged to 387 
amino acid metabolism with all being down-regulated in land-locked salmon regardless of 388 
dietary treatment. Two DEG in the lipid metabolism category belonged to ether lipid 389 
metabolism (ectonucleotide pyrophosphatase and phospholipase D3/4) although regulated in 390 
opposite directions, while decaprenyl-diphosphate synthase subunit 2, involved in terpenoid 391 
backbone biosynthesis displayed the highest negative FC (-4.19) within lipid metabolism 392 
(Supplementary Table 3). The top 100 most significant genes included those involved in 393 
glucose metabolism such as the glycolytic enzyme 6-phosphofructokinase 1 (6pfk) that was 394 
strongly up-regulated (+3.73) and the gluconeogenic enzyme pyruvate carboxylase (pc) that 395 
Fig. 5 
here 
Fig. 6 
here 
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was down-regulated (-1.69). Two pathways closely related to carbohydrate (insulin pathway) 396 
and lipid metabolism (PPAR signalling pathway) were present in the top 100 category list. 397 
Protein phosphate 1 regulatory subunit 3A, belonging to the insulin signalling pathway 398 
displayed a -1.67 FC down-regulation, whereas the two genes belonging to the PPAR 399 
signalling pathway showed divergent regulation, with intestinal fatty acid binding protein up-400 
regulated (+2.06) and fatty acid transporter (solute carrier family 27) down-regulated (-1.50). 401 
The microarray data were validated by qPCR by comparing the expression of 5 genes 402 
belonging to the LC-PUFA biosynthesis pathway (Supplementary Table 4). Good 403 
correspondence in terms of intensity (FC) of direction of change (up- or down-regulated) was 404 
observed among all the studied genes (100 %). The match was also consistent in terms of 405 
significance (p value) when comparing microarray and qPCR results (80 %; 4 out of 5). 406 
 407 
4. Discussion 408 
Finding alternative dietary sources to substitute for FO in aquafeeds is one priority in 409 
aquaculture nutrition. Although most research has focussed on testing alternative raw 410 
materials such as vegetable oils [10,24,27-28], microalgal lipids [29-30] or de novo sources 411 
of omega-3 [31-32], there has been less effort investigating the n-3 trait in fish. It is known 412 
that both fatty acid deposition and the activity of the bioconversion pathway are dependent on 413 
the genetic background of the fish [14,33-34] and the level of n-3 LC-PUFA in flesh was 414 
shown to be highly heritable trait in salmon [7]. However, it is also known that changes in 415 
dietary lipid source can alter the genetic potential, as well as the magnitude and direction of 416 
response between family groups [24,27]. In the present study, a two-factorial design 417 
nutritional trial was employed to elucidate the potential of parr from a land-locked Atlantic 418 
salmon population (only ever exposed to freshwater) compared to parr from a farmed 419 
anadromous stock (exposed to seawater every generation) when fed diets formulated with 420 
fish oil (FO) and rapeseed oil (RO). 421 
A major finding in the present study was that there were differences in n-3 LC-PUFA 422 
metabolic trait between the two salmon populations with definite indications that the land-423 
locked population may have higher potential for n-3 LC-PUFA biosynthesis than the farmed 424 
stock. Thus, a clear result was the higher expression of the LC-PUFA biosynthesis genes 425 
including fads2d6, fads2d5, elovl2 and elovl5a, in land-locked salmon compared to the 426 
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farmed stock when fed FO. This was reflected in the activity of the LC-PUFA biosynthesis 427 
pathway in hepatocytes with increased recovery of radioactivity from labelled 18:3n-3 being 428 
found in all intermediates and products of the pathway in the WFO group compared to the 429 
FFO group. However, the same situation was not found in fish fed the RO diet because, 430 
although the activity of the LC-PUFA biosynthesis pathway was higher in the land-locked 431 
salmon (WRO) than in the farmed stock (FRO), this was not a reflection of gene expression 432 
as there was no difference between the populations in the expression of any of the LC-PUFA 433 
biosynthetic genes when fed RO other than elovl5b, which actually showed lower expression 434 
in the WRO group. Therefore, the expression of the genes in the two populations was not 435 
fully reflected in the activities of the enzymes. This variation with diet was unexpected and 436 
the mechanism unclear from these data alone. 437 
However, further insight was provided by comparing the effect of diet within the populations. 438 
Thus, the farmed population showed a very clear response to diet with the expression of all 439 
genes, especially the fads, being higher in fish fed the RO diet compared to fish fed the FO 440 
diet. Similarly, the activity of the LC-PUFA biosynthetic pathway in hepatocytes was 441 
significantly higher in the FRO group compared to the FFO group. This was entirely 442 
consistent with many previous studies investigating the LC-PUFA biosynthesis pathway in 443 
salmon from farmed stocks, with fish fed vegetable oil, including rapeseed, diets showing 444 
higher expression of LC-PUFA genes (especially fads) [24,31,35-40] and higher enzymatic 445 
activity of the pathway in hepatocytes [16,37,40-43] than fish fed fish oil diets. In contrast, 446 
the land-locked population did not show the same response to the RO diet with no increased 447 
expression of any of the genes involved in LC-PUFA biosynthesis and no increased activity 448 
of the biosynthetic pathway in hepatocytes compared to fish fed FO diet.  449 
Therefore, whereas the results for the farmed population were consistent with previous 450 
studies, the land-locked population showed important differences. Firstly, land-locked salmon 451 
displayed higher LC-PUFA biosynthetic capacity than farmed fish, irrespective of diet. 452 
However, gene expression in liver of land-locked fish only paralleled biosynthetic activity in 453 
hepatocytes in fish fed FO and not in fish fed RO and, furthermore, land-locked salmon did 454 
not respond to the RO diet in the same way as farmed fish have been shown to. This gives a 455 
clue to one of the genetic differences between these two populations. The many studies in 456 
salmon using fish from farmed stock fed FO and VO diets have led to the conclusion that the 457 
higher activity and gene expression in fish fed VO was due to dietary LC-PUFA in fish oil 458 
suppressing expression of the genes of LC-PUFA biosynthesis, especially the fads [35-36,44-459 
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46] but, to a lesser extent, perhaps also elongases [47]. It has been established more recently 460 
that the suppression is due specifically to DHA as EPA was not effective in suppressing LC-461 
PUFA biosynthesis [40] or expression of the biosynthetic genes [32]. Taking all the data 462 
obtained together the present study has suggested that the land-locked salmon are perhaps 463 
less influenced by dietary fatty acid composition and, specifically, less sensitive to dietary 464 
DHA. Thus, the expression of the LC-PUFA biosynthetic genes, and consequent biosynthesis 465 
pathway activity, are not suppressed in fish fed the FO diet. The molecular mechanism for 466 
this is not clear but is possibly related to differences in the upstream regulatory UTR 467 
(promoter) region of the genes [48]. It is interesting to speculate on whether this is an 468 
evolutionary adaptation to a natural diet lower in DHA [44]. The argument being that upon 469 
moving to seawater, anadromous salmon start consuming a diet with high levels of DHA and 470 
as an adaptation to that, a mechanism evolved preventing unnecessary biosynthesis. In land-471 
locked salmon this mechanism was lost due to the fact that DHA was no longer a major 472 
component of the diet and evolutionary pressure for the mechanism was relieved. However, 473 
domestication itself could potentially affect the regulation of LC-PUFA metabolism as it has 474 
been suggested that domestication may be sufficient to induce heritable alterations in 475 
transcription levels compared to wild populations [49-51]. 476 
However, the fact that, irrespective of diet, the activity of the biosynthetic pathway was 477 
higher in land-locked salmon compared to farmed salmon may suggest other differences in 478 
the fads and/or elovl genes, perhaps even in primary sequence. Studies in the human have 479 
demonstrated that cellular fatty acid compositions are influenced by SNPs in the FADS1 and 480 
FADS2 gene cluster [52-54]. Furthermore, it has been shown previously that there are 481 
potentially three functional fads2d6 (6) genes in Atlantic salmon and each appeared to show 482 
a different pattern of regulation in response to dietary VO in a farmed salmon stock [55]. A 483 
further interesting factor to consider in evaluating differences between farmed and land-484 
locked populations is 8 desaturase activity, which is an inherent property of 6 desaturases, 485 
and that catalyses the conversion of 20:3n-3 to 20:4n-3 [56]. Traditionally 20:3n-3 had been 486 
considered a “dead-end” product in the biosynthesis of n-3 LC-PUFA as it was not regarded 487 
as an intermediate in the desaturation-elongation pathway [45]. In the present study, the 488 
amount of radioactivity recovered in 20:3n-3 (and 20:4n-3) was lower in the land-locked 489 
population compared to the farmed population whereas the recovery of radioactivity in 20:4n-490 
3 was higher in the land-locked fish. However, there was also increased recovery of 491 
radioactivity in 18:4n-3 in land-locked fish (resulting from 6 desaturation of 18:3n-3) and so 492 
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the source of radioactivity in 20:4n-3 could be from either 6 or 8 activity. Studies on the 493 
Δ8 desaturase activity of several fish species showed that FADS2D6 of diadromous fish 494 
species such as the Atlantic salmon exhibited limited Δ8 desaturation activity, especially 495 
when compared with seawater teleost [56]. The lower proportion of radioactivity recovered in 496 
20:3n-3 in the present study may suggest that land-locked salmon FADS2D6 might have an 497 
enhanced Δ8 activity compared to their farmed counterparts. Studies evaluating polymorphic 498 
variation in the salmon genome could be insightful as the previous studies on SNPs in the 499 
human FADS1-FADS2 desaturase gene cluster have indicated [52-54]. The molecular 500 
mechanism(s) of the differences in LC-PUFA biosynthetic capacity between the farmed and 501 
land-locked stocks are clearly of interest and worthy of further studies in the future.  502 
There was no indication of any substantial LC-PUFA biosynthesis observed in the flesh of 503 
either population of salmon as both strains primarily reflected the dietary fatty acid 504 
compositions as also reported previously [14]. This was not surprising taking into account the 505 
role of muscle in salmon as a lipid storage tissue with limited metabolic activity [5]. Several 506 
studies have shown that, whereas salmon muscle (flesh) closely reflects dietary fatty acid 507 
composition [5,57-58], liver fatty acid composition reflects the higher metabolic activity, 508 
including LC-PUFA biosynthesis, in that tissue [31-32]. However, desaturase expression and 509 
activity in one tissue can affect fatty acid composition in another as demonstrated in poultry 510 
[59-60]. Therefore, in the present study, we focused on investigating whether flesh 511 
compositions reflected any potential genetic differences between the populations and, simply 512 
looking at overall compositions, that appeared not. However, the PCA analysis showed an 513 
interesting difference between the two populations in the correlation/association between 514 
flesh n-3 LC-PUFA levels and the expression of the LC-PUFA biosynthesis genes in the 515 
liver. Previously, this analyses had shown that Atlantic salmon fed camelina products 516 
displayed a link between 22:5n-3 and DHA levels and elovl5a transcript level [28]. In the 517 
present study, all the biosynthetic genes other than fads2d6, which clustered with the main 518 
end-point fatty acids ARA and DHA, clustered with n-3 PUFA in land-locked salmon 519 
whereas all the genes clustered with n-6 PUFA in farmed population. While this result 520 
demonstrates a clear difference between the populations in the relationship between flesh 521 
fatty acids and liver gene expression the precise mechanism underpinning the data is unclear.  522 
Apart from enhanced n-3 LC-PUFA biosynthetic capacity, land-locked salmon from the 523 
Gullspång Swedish stock displayed higher growth in terms of SGR than the farmed stock 524 
independent of diet, indicating that overall fish performance was affected by population. 525 
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Similar results were reported in a previous study on another land-locked salmon population 526 
(Penobscott strain), which showed higher daily growth rate than a farmed stock [14]. Thus, it 527 
is likely that several physiological processes, rather than just LC-PUFA metabolism may vary 528 
between farmed and land-locked salmon populations that allow the latter fish to better utilise 529 
dietary nutrients to promote growth. It was in this context that liver transcriptome was 530 
analysed in the present study. This analysis indicated that metabolism was a highly affected 531 
category and, within metabolism, carbohydrate, lipid and energy metabolism showed a large 532 
number of genes whose expression varied depending on the genetic background. Lipid and 533 
glucose metabolism are principally regulated by insulin and previous studies in rainbow trout 534 
(Oncorhynchus mykiss) demonstrated diverging patterns of expression in glucose and lipid-535 
related genes between two experimental lines developed for high (fat) or low (lean) muscle 536 
fat when insulin was administered [61]. Dietary glucose functions mainly as a fuel through 537 
the glycolytic pathway or, in excess, is converted to lipids for storage. Expression of 6pfk, the 538 
most important regulatory enzyme in glycolysis, was up-regulated in land-locked salmon 539 
whereas pk, a key enzyme in the synthesis of glucose was down-regulated. This increased 540 
potential for glucose catabolism was accompanied by stimulation in lipogenic gene 541 
expression (fas, g6pd, and pparg) as well as an inhibition in lipolysis pathways (cpt2, hoad 542 
and aco). These results suggested that the land-locked salmon had a higher capacity for 543 
lipogenesis together with limited lipolysis as well as an enhanced utilization of glucose as a 544 
source of energy that could, in part, contribute to higher growth rate. This is contrary to the 545 
generally accepted view that carnivorous fish such as Atlantic salmon have a limited ability 546 
to use dietary carbohydrates efficiently [62]. However, previous studies in rainbow trout 547 
demonstrated enhanced glycolytic potential as well as decreased fatty acid oxidation in the 548 
liver of a selected fat line [63] although no differences in the expression of glycolytic or fatty 549 
acid oxidation genes were found among Atlantic salmon families with high or low fat content 550 
in muscle [24]. As mentioned above, it is also possible that differences in metabolism 551 
between populations could be influenced by domestication and the fact that food acquisition 552 
is not a threat to survival in farmed populations. In this respect, differential expression in 553 
several metabolic pathways was found between farmed and wild salmon populations at early 554 
life stages suggesting that domestication may influence transcriptomic responses (49-51). 555 
The genetic background of the two populations also appeared to have an effect on the insulin 556 
pathway as up-regulation of pi3k and raptor was found in land-locked salmon. In mammals 557 
insulin activates pi3k that phosphorylates a number of downstream proteins such as raptor 558 
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[64]. Some of the effects of insulin are to promote the uptake of fatty acids, to increase 559 
lipogenesis and inhibit fatty acid oxidation [61,65], which are the effects observed in the 560 
land-locked salmon. Thus, our results may indicate that, in addition to enhanced glycolytic 561 
and lipogenic potential and decreased fatty acid oxidation, the regulatory effect of insulin 562 
might be stronger in land-locked than in farmed salmon. However, previous studies in fish 563 
have not shown a correlation between enhanced lipid/carbohydrate metabolism and insulin 564 
regulation [61] and thus more studies are required to elucidate the influence of insulin 565 
regulation on metabolism of land-locked and farmed salmon populations.  566 
The metabolism of glycerophospholipids (phospholipids) was one of the lipid metabolic 567 
pathways that differed between the land-locked and farmed salmon, which agreed with a 568 
previous study where this pathway was down-regulated in a lean Atlantic salmon line in 569 
contrast to a fat line [24]. Phospholipids are the main components in cell membranes and play 570 
a major role in maintaining the structure and functions of cell membranes as well as energy 571 
production [66]. Two enzymes that act consecutively in the pathway, agpat and ppap2, 572 
showed higher expression levels in land-locked salmon. agpat converts lysophosphatidic acid 573 
into phosphatidic acid whereas ppap2 catalyses the dephosphorylation of phosphatidic acid 574 
yielding diacylglycerol [67]. Both phosphatidic acid and diacylglycerol can act as second 575 
messengers [68-69] potentially leading to an alteration in the levels of lipid signalling 576 
molecules which could in turn affect several key physiological processes influencing growth 577 
performance. Similarly agpat was up-regulated in the fat Atlantic salmon line [24]. 578 
Additionally two phospholipases, secretory phospholipase A2 and phospholipase D4, 579 
enzymes that hydrolyse the ester bond at the sn-2 position of membrane phospholipids, also 580 
showed higher expression in the liver of land-locked salmon. The released fatty acids 581 
(particularly EPA and ARA) are substrates for the production of eicosanoids, a range of 582 
highly bioactive derivatives implicated in many physiological processes [5]. The remaining 583 
lysophospholipid also has important roles in several biological processes such as stimulation 584 
of preadipocyte proliferation and differentiation [70-71]. Thus, this range of highly 585 
biologically active products obtained from the actions of phospholipases may act as 586 
mediators of metabolism contributing to the physiological differences observed between 587 
land-locked and farmed salmon stocks.  588 
In conclusion, the present study indicated a higher capacity to synthesise n-3 LC-PUFA in the 589 
liver of land-locked salmon than in their farmed counterparts regardless of dietary fatty acid 590 
composition. Increased expression of enzymes (desaturases and elongases) involved in this 591 
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pathway was generally observed in land-locked salmon compared to the farmed salmon stock 592 
regardless of dietary treatment and this was associated with higher activity in the biosynthetic 593 
pathway. Apart from an enhancement in desaturation/elongation activities, high lipogenic and 594 
glycolytic potential were found in land-locked salmon, together with decreased lipolysis 595 
which in turn could indicate increased use of carbohydrates as an energy source and a sparing 596 
of lipid. This hypothesis was reinforced by the up-regulation found in the insulin pathway. 597 
However, the fatty acid of flesh reproduced dietary contents and thus the enhanced LC-PUFA 598 
biosynthetic capability of Atlantic land-locked salmon was not reflected. It must be noted 599 
thought that firstly, the trial had a short duration (8 weeks) and maybe not enough time was 600 
given so that the dietary n-3 LC-PUFA could be deposited and stored by the fish muscle. 601 
Secondly, only total lipid fatty acids were analysed and triglycerides can dilute the total 602 
percentage of DHA incorporated into the phospholipids. 603 
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Legends to Figures 828 
 829 
Fig. 1. Expression of genes of the LC-PUFA biosynthesis pathway in Atlantic salmon liver 830 
as determined by qPCR. Results are normalised expression ratios (means ± SEM; n = 6). F, 831 
farmed salmon; W, land-locked salmon; FO, fish oil diet; RO, rapeseed oil diet. fads2d6, 832 
delta-6 fatty acyl desaturase; fads2d5, delta-5 fatty acyl desaturase; elovl2, fatty acyl 833 
elongase 2; elovl5a, fatty acyl elongase 5 isoform a; elovl5b, fatty acyl elongase 5 isoform b. 834 
Different superscript letters denote differences among treatments identified by one-way 835 
ANOVA. The inset Table presents p values for the effect of diet, population and their 836 
interaction on the relative gene expression. 837 
 838 
Fig. 2. Principal component analysis of flesh fatty acid data (%) and expression of lipid 839 
metabolism genes in liver (log2 FC). (A) Farmed salmon fed both dietary treatments. (B) 840 
Land-locked salmon fed both fish oil and rapeseed oil diets. After performing PCA, 841 
components scores were clustered according to the Ward’s method followed by K-means 842 
cluster in order to quantitatively define the relationships observed in the PCA 843 
 844 
Fig. 3. Hierarchical cluster (10000 randomisations) showing the distribution of the 845 
normalised data from the microarray analysis. F, farmed salmon; W, land-locked salmon; 846 
FO, fish oil diet; RO, rapeseed oil diet. 847 
 848 
Fig. 4 Functional categories of genes differentially expressed in farmed (F) or land-locked 849 
(W) Atlantic salmon after 8 weeks of feeding fish oil (FO) or rapeseed oil (RO) diets. Genes 850 
differentially expressed according to two-way ANOVA analysis (p < 0.05) between the two 851 
diets (A), the population groups (B) as well as due to the interaction of both factors (C). 852 
Non-annotated genes and features corresponding to the same gene are not represented.  853 
 854 
Fig. 5 Bubble chart representing the top 30 categories with a highest number of DEG from 855 
the list of genes exclusively regulated by population. The area of the circle is scaled to the 856 
number of DEG within each pathways (17-80 DEG). Each colour represents a different 857 
category; Genetic Information (blue), Environmental Information Processing (green), 858 
Cellular Processes (yellow), Organismal System (red) and Metabolism (purple)  859 
 860 
30 
 
Fig. 6 Bubble chart representing the number of affected genes within each metabolism 861 
category. The area of the circle is scaled to the number of DEG within each pathways (32-862 
157 DEG). (B) KEGG pathway analysis of genes belonging to category of metabolism that 863 
were exclusively regulated by population as indicated by two-way ANOVA analysis  Each 864 
colour indicated a different nutrient metabolism. * p<0.05; ** p<0.01; *** p<0.001. 865 
 866 
  867 
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Table 1- Formulation (% of the feed ingredients indicated) Formulations, proximate and fatty 868 
acid compositions (percentage of fatty acids) of the experimental feeds  869 
 870 
 871 
 872 
 873 
 874 
 875 
 876 
 877 
 878 
 879 
 880 
 881 
 882 
 883 
 884 
 885 
 886 
 887 
 888 
 889 
1contains 15:0, 22:0 and 24:0; 2contains 16:1n-9, 20:1n-11, 20:1n-7, 22:1n-9 and 24:1n-9; 3contains 890 
22:4n-6 and 22:5n-6; 4contains C16 PUFA. Fish and FO, fish oil and respective feed; LC- PUFA, 891 
long-chain polyunsaturated fatty acid (sum of 20:4n-3, 20:5n-3 22:5n-3 and 22:6n-3); n.d. not 892 
detected. 893 
  894 
 FO RO 
Fish meal 33.5 33.5 
Soy protein concentrate 20.0 20.0 
Fish oil 17.0 - 
Rapeseed oil - 17.0 
Wheat 10.0 10.0 
Wheat gluten 15.0 15.0 
Vitamin mix 2.0 2.0 
Mineral mix 0.5 0.5 
Monosodium phosphate 2.0 2.0 
Analysed composition    
Dry matter (%) 91.1 91.3 
Protein (%) 50.0 49.4 
Fat (%) 15.1 15.2 
Ash 8.1 8.0 
Fatty acid composition (%)   
Ʃ saturated1 22.4 14.2 
Ʃ monounsaturated2 45.8 53.3 
18:2n-6 7.0 16.6 
20:2n-6 0.2 0.1 
20:3n-6 0.0 0.1 
20:4n-6 0.4 0.1 
Ʃ n-6 PUFA3 7.9 17.1 
18:3n-3 1.6 6.0 
20:3n-3 0.15 0.05 
20:4n-3 0.5 0.2 
20:5n-3 7.0 2.9 
22:5n-3 0.7 0.3 
22:6n-3 9.6 4.6 
Ʃ n-3 PUFA 22.6 15.1 
Ʃ PUFA4 31.7 32.5 
Total n-3 LC-PUFA 17.3 7.8 
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Table 2.- Growth performance, survival, feed utilisation and specific growth rate of Atlantic 895 
salmon from the two studied stocks after 8 weeks of feeding the experimental diets. 896 
 897 
Data are means ± SD (n=3). Different superscript letters within a row denote significant 898 
differences among the diets and stocking conditions. SGR, specific growth rate , S, farmed 899 
salmon; W, land-locked salmon; FO, fish oil diet; RO, rapeseed oil diet; POP, population; D, diet. * 900 
p<0.05; ** p<0.01; n.s. not significant. 901 
 902 
  903 
 FO RO p value two-way 
ANOVA 
 F W F W POP D POP*D 
Initial 
weight (g) 
 
31.2±0.9a 24.7±0.3b 30.5±0.8a 24.9±0.3b ** n.s. n.s. 
Final weight 
(g) 
 
58.4±1.7 57.4±2.9 57.8±2.5 57.8±3.2 n.s. n.s. n.s. 
K factor 
 
1.30±0.01a 1.43±0.04b 1.29±0.00a 1.44±0.003b ** n.s. n.s. 
Survival (%) 100 100 100 100 n.s. n.s. n.s. 
SGR 1.6±0.2b 2.1±0.1a 1.6±0.1b 2.1±0.1a ** n.s. n.s. 
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Table 3.- Lipid content (percentage of wet weight) and fatty acid compositions (percentage of 904 
total fatty acids) of total lipid from muscle tissues (flesh) of Atlantic salmon after 8 weeks of 905 
feeding the experimental feeds 906 
 907 
Data expressed as means ± SD (n=12). Different superscript letters within a row denote 908 
significant differences among diets determined by one-way ANOVA with Tukey’s 909 
comparison test (p<0.05). 1contains 15:0, 22:0 and 24:0; 2contains 16:1n-9 and 24:1n-9; 910 
3contains 22:4n-6 and 22:5n-6; 4contains C16 PUFA. FO, fish oil feed; RO; rapeseed oil feed; 911 
F, farmed salmon stock; W, Gullspång strain. * p<0.05; ** p<0.01; n.s. not significant. 912 
  913 
 FO RO Two-way ANOVA p 
 F W F W POP D POP*D 
Lipid content  2.8±1.3 2.4±0.7 3.0±1.0 3.6±1.7 n.s. n.s. n.s. 
14:0 3.9±0.3a 3.9±0.2a 2.7±0.2b 2.7±0.4b n.s. ** n.s. 
16:0 15.9±0.7a 16.3±0.3a 13.5±0.7b 13.8±0.8b n.s. ** n.s. 
18:0 3.4±0.1 3.3±0.1 3.2±0.2 3.3±0.1 n.s. * n.s. 
20:0 0.2±0.0bc 0.1±0.0c 0.2±0.1ab 0.2±0.1a n.s. ** n.s. 
Σ saturated1 23.8±0.6a 24.0±0.5a 20.0±0.7b 20.2±1.1b n.s. ** n.s. 
16:1n-7 4.3±0.4a 4.5±0.3a 3.0±0.3b 3.0±0.5b n.s. ** n.s. 
18:1n-9 18.8±1.5b 18.3±1.0b 28.5±2.1a 30.4±4.6a n.s. ** n.s. 
18:1n-7 2.8±0.2ab 2.6±0.1b 2.9±0.2a 2.9±0.3a n.s. ** n.s. 
20:1n-11 0.9±0.1a 0.9±0.1a 0.4±0.0b 0.5±0.1b n.s. ** n.s. 
20:1n-9 6.0±0.6a 6.1±0.4a 4.3±0.3b 4.6±0.6b n.s. ** n.s. 
20:1n-7 0.2±0.0a 0.2±0.0a 0.2±0.0b 0.2±0.0b n.s. ** n.s. 
22:1n-11 6.4±0.8a 6.6±0.6a 3.6±0.3b 3.8±0.7b n.s. ** n.s. 
22:1n-9 0.5±0.1a 0.6±0.0a 0.4±0.0b 0.1±0.1b n.s. ** n.s. 
Σ monoenes2 41.1±3.2b 40.9±2.3b 44.3±3.1ab 46.7±4.9a n.s. ** n.s. 
18:2n-6 6.3±0.6b 5.7±0.3b 9.9±0.8a 10.3±1.7a n.s. ** n.s. 
18:3n-6 0.1±0.0b 0.1±0.0b 0.2±0.0a 0.2±0.0a n.s. ** n.s. 
20:2n-6 0.6±0.1b 0.5±0.0b 0.9±0.1a 0.9±0.1a n.s. ** n.s. 
20:3n-6 0.2±0.0b 0.2±0.0b 0.4±0.1a 0.5±0.1a n.s. ** n.s. 
20:4n-6 0.5±0.1 0.5±0.1 0.5±0.1 0.4±0.1 n.s. * n.s. 
Σ n-6 PUFA3 7.9±0.6b 7.3±0f.3b 12.1±0.8a 12.5±1.8a n.s. ** n.s. 
18:3n-3 2.0±1.1b 1.4±0.1b 3.1±0.2a 3.1±0.6a n.s. ** n.s. 
18:4n-3 1.5±0.1a 1.4±0.1a 1.1±0.1b 1.0±0.1b n.s. ** n.s. 
20:3n-3 0.2±0.0b 0.2±0.0b 0.3±0.0a 0.3±0.0a n.s. ** n.s. 
20:4n-3 0.9±0.0b 0.8±0.0b 0.7±0.0a 0.6±0.1a n.s. ** ** 
20:5n-3 4.1±0.5a 3.9±0.6a 2.7±0.3b 2.4±0.7b n.s. ** n.s. 
22:5n-3 1.5±0.1a 1.5±0.1a 1.0±0.1b 0.9±0.2b n.s. ** * 
22:6n-3 17.1±2.9a 16.7±1.9a 13.4±2.1b 12.1±3.2b n.s. ** n.s. 
Σ n-3 PUFA 27.2±3.0a 25.8±2.2a 22.2±2.2b 20.4±3.9b n.s. ** n.s. 
Σ PUFA4 35.6±2.6 33.7±2.1 34.9±1.6 33.3±2.7 n.s. n.s. n.s. 
Σ n-3 LC-PUFA 22.7±3.4a 22.1±2.2a 17.2±2.4b 15.4±4.4b n.s. ** n.s. 
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Table 4.- Elongation and desaturation (pmol/mg protein/h) of [1-14C]18:3n-3 in landlocked 914 
Atlantic salmon hepatocytes. 915 
 916 
Results are means ± SE (n=12). F, farmed salmon; W, land-locked salmon; FO, fish oil diet; RO, 917 
rapeseed oil diet. Different superscript letters within an individual column denote significant statistical 918 
differences in fatty acid content according to one-way ANOVA. * p<0.05; ** p<0.01; n.s. not 919 
significant. 920 
  921 
 Elongation Desaturation 
 20:3n-3 Total 18:4n-3 20:4n-3 20:5n-3 22:5n-3 22:6n-3 
FFO 5.5±0.7bc 
(50.0%) 
4.7±0.3c 1.2±0.1c 
(14.9%) 
1.4±0.1c 
(12.7%) 
0.7±0.1c 
(9.8%) 
0.9±0.1c 
(8.0%) 
0.4±0.0b 
(4.6%) 
WFO 7.3±0.4ab 
(45.7%) 
8.9±0.4a 2.0±0.1a 
(15.9%) 
2.6±0.2a 
(12.5%) 
1.7±0.2ab 
(11.7%) 
1.9±0.1a 
(10.6%) 
0.6±0.1b 
(3.8%) 
FRO 7.7±0.5a 
(51.5%) 
6.7±0.3b 1.5±0.0b 
(14.7%) 
2.0±0.1bc 
(10.5%) 
1.2±0.1bc 
(10.5%) 
1.4±0.1b 
(9.1%) 
0.5±0.0b 
(3.7%) 
WRO 4.6±0.3c 
(32.9%) 
9.2±0.5a 1.7±0.1ab 
(17.0%) 
2.3±0.1b 
(12.0%) 
1.7±0.1a 
(17.6%) 
2.4±0.2a 
(12.2%) 
1.1±0.2a 
(8.3%) 
        
Population n.s. ** ** ** ** ** ** 
Diet n.s. ** n.s. n.s. ** n.s. ** 
Interaction ** * ** ** n.s. * n.s. 
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Supplementary Table 1.- Primer used for qPCR analysis 922 
Transcript Primer sequence (5’→3’) Amplicon (bp) Ta Accession no 
fads2d6 F: TCCTCTGGTGCGTACTTTGT 163 59˚C NM_001123575.2a 
R: AAATCCCGTCCAGAGTCAGG 
fads2d5 F: GCCACTGGTTTGTATGGGTG 148 59˚C NM_001123542.2a 
R: TTGAGGTGTCCACTGAACCA 
elovl2 F: GGTGCTGTGGTGGTACTACT 190 59˚C NM_001136553.1a 
R: ACTGTTAAGAGTCGGCCCAA 
elovl5a F: TGTTGCTTCATTGAATGGCCA 150 59˚C GU238431.1a 
R: TCCCATCTCTCCTAGCGACA 
elovl5b F: CTGTGCAGTCATTTGGCCAT 192 59˚C NM_001136552.1a 
R: GGTGTCACCCCATTTGCATG 
cfl2 F: AGCCTATGACCAACCCACTG 224 60˚C TC63899b 
R: TGTTCACAGCTCGTTTACCG 
ef1a F: CTGCCCCTCCAGGACGTTTACAA 175 60˚C AF321836a 
R: CACCGGGCATAGCCGATTCC 
 923 
a GenBank (http://www.ncbi.nlm.nih.gov) 924 
b Atlantic salmon Gene Index (http://compbio.dfci.harvard.edu/tgi) 925 
fads2d6, delta-6 fatty acyl desaturase; fads2d5, delta-5 fatty acyl desaturase; elovl2, fatty acyl 926 
elongase 2; elovl5a, fatty acyl elongase 5 isoform a; elovl5b, fatty acyl elongase isoform b; 927 
cfl2, cofilin 2; ef1a, elongation fcator 1 alpha. 928 
 929 
  930 
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 932 
KO no Annotation FC 
Metabolism (33%)   
Carbohydrate (8%)   
K01069 Hydroxyacylglutathione hydrolase +2.53 
K00846 Ketohexokinase -1.47 
K00850 6-phosphofructokinase 1 +3.73 
K01958 Pyruvate carboxylase -1.69 
K00780 Beta-galactoside alpha-2,3-sialyltransferase -1.98 
K01641 Hydroxymethylglutaryl-CoA synthase +2.98 
K13247 L-gulonate 3-dehydrogenase +1.24 
K00699 Glucuronosyl transferase -1.30 
Lipids (8%)   
K01122 Ectonucleotide pyrophosphatase -1.65 
K05929 Phosphoethanolamine N-methyltransferase -1.37 
K05309 Microsomal prostaglandin-E synthase 2 +1.54 
K16860 Phospholipase D3/4 +2.06 
K12505 Decaprenyl-diphosphate synthase subunit 2 -4.19 
K07439 24-hydroxycholesterol 7 alpha-hydroxylase -1.36 
K07424 Cytochrome P450, family3, subfamily A +1.32 
K01047 Secretory phospholipase A2 +2.08 
Aminoacids (6%)   
K00261 Glutamate dehydrogenase (NAD(P)+) +1.64 
K01620 Threonine aldolase +1.50 
K00544 Betaine-homocysteine S-methyltransferase +2.49 
K00933 Creatine kinase +1.27 
K01581 Ornithine decarboxylase +2.19 
K00544 Betaine-homocysteineS-methyltransferase +2.49 
Energy (4%)   
K02263 Cytochrome c oxidase subunit 4 -1.75 
K18246 Carbonic anhydrase 4 +6.43 
K02260 Cytochrome c oxidase assembly protein subunit 17 -1.49 
K17218 Sulfide:quinone oxidoreductase -15.51 
Nucleotide (4%)   
K00940 Nucleoside-diphosphate kinase +1.80 
K11540 Carbamoyl-phosphate synthase -1.58 
K00758 Thymidine phosphorylase -1.37 
K00939 Adenylate kinase -1.17 
Other (3%)   
K00275 Pyridoxamine 5'-phosphate oxidase -1.20 
K13624 Ceruloplasmin  +1.31 
K10106 Vitamin K-dependent gamma-carboxylase +1.22 
Translation (18%)   
Ribosome (14%)   
K02940 Large subunit ribosomal protein L9e -1.77 
K02936 Large subunit ribosomal protein L7Ae -1.40 
K02978 Small subunit ribosomal protein S27e -1.17 
K02885 Large subunit ribosomal protein L19e -1.23 
K02898 Large subunit ribosomal protein L26e +1.35 
K02966 Small subunit ribosomal protein S19e -1.17 
K02876 Large subunit ribosomal protein L15 +1.33 
Supplementary Table 3. Liver transcripts corresponding to the top 100 most significant annotated features exhibiting 
common differential expression between land-locked and farmed salmon (W vs F). Features are arranged by functional 
categories and within them by increasing p value (assessed by two-way ANOVA). The percentages of genes distribution 
is represented after removing features belonging to the same gene. 
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K02883 Large subunit ribosomal protein L18e -1.31 
K02987 Small subunit ribosomal protein S4e +2.41 
K02930 Large subunit ribosomal protein L4e -1.23 
K02974 Small subunit ribosomal protein S24e -1.15 
K02989 Small subunit ribosomal protein S5e -1.21 
K02915 Large subunit ribosomal protein L34e -1.52 
K02877 Large subunit ribosomal protein L15e -1.18 
RNA transport (4%)   
K03262 Translation initiation factor 5 +2.92 
K13130 Survival of motor neuron protein-interacting protein 
1 +1.31 
K12160 Small ubiquitin-related modifier +1.52 
Signal transduction (17%)   
mTOR signalling pathway (1%)   
K08269 Serine/threonine-protein kinase ULK/ATG1  +1.41 
Jak-STAT signalling pathway (1%)   
K05069 Interleukin 2 receptor beta -2.08 
Cell adhesion molecules (2%)   
K06087 Claudin +2.22 
K06736 Cadherin 2, type 1, N-cadherin +1.49 
NF-kappaB signalling pathway (3%)   
K04725 E3 ubiquitin-protein ligase XIAP -1.52 
K07371 B-cell linker protein -1.19 
K10652 Tripartite motif-containing protein 25 -1.72 
AMPK signalling pathway (2%)   
K00850 6-phosphofructokinase 1 +3.73 
K07881 Ras-related protein Rab-14 +2.01 
Ras signalling pathway (2%)   
K07836 Ras-related protein Rap-1B +1.67 
K02183 Calmodulin +1.36 
TNF signalling pathway (1%)   
K14625 C-C motif chemokine 20 +3.05 
Rap1 signalling pathway (1%)   
K04294 Lysophosphatidic acid receptor 3 -2.63 
FoxO signalling pathway (2%)   
K07199 5'-AMP-activated protein kinase +1.18 
K10628 V(D)J recombination-activating protein 1 -4.44 
MAPK signalling pathway (1%)   
K04437 Filamin +1.30 
Transport and catabolism (8%)   
Lysosome (2%)   
K01371 Cathepsin K +2.34 
K12399 AP-3 complex subunit sigma +1.29 
Endocytosis (1%)   
K12484 Rab11 family-interacting protein 1/2/5 +1.88 
Peroxisome (3%)   
K13279 Peroxiredoxin 1 -1.69 
K01640 Hydroxymethylglutaryl-CoA lyase  -2.15 
K12663 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase  -1.31 
Phagosome (2%)   
K03990 Complement component 3 -1.56 
K13813 Syntaxin 12/13 +1.81 
Folding, sorting and degradation (8%)   
Ubiquitin mediated proteolysis (3%)   
K10610 DNA damage-binding protein 1 -1.77 
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 933 
 934 
  935 
K10615 E3 ubiquitin-protein ligase HERC4 -4.01 
K10587 Ubiquitin-protein ligase E3 A  -4.73 
Protein processing in ER (5%)   
K09554 Cyclic AMP-dependent transcription factor ATF-6 
α 
+1.81 
K09555 BCL2-associated athano gene 1 -1.74 
K13251 Translocon-associated protein subunit gamma +13.64 
K14018 Phospholipase A-2-activating protein +1.49 
K01367 calpain-1 +1.41 
Immune system (6%)   
Complement and coagulation (6%)   
K03905 Fibrinogen gamma chain -1.76 
K01334 Component factor D +2.37 
K03904 Fibrinogen beta chain +3.38 
K03910 Alpha-2-macroglobulin +1.37 
K03909 Tissue factor pathway inhibitor +1.52 
K03990 Complement component 3 -1.56 
Transcription (4%)   
Spliceosome (3%)   
K12627 U6 snRNA-associated Sm-like protein LSm8 -1.32 
K12846 U4/U6.U5 tri-snRNP-associated protein 3 -1.40 
K12733 Peptidyl-prolyl cis-trans isomerase-like 1  -2.38 
DNA replication (2%)   
K02542  DNA replication licensing factor MCM6 -3.17 
K02212  DNA replication licensing factor MCM4 -1.93 
Endocrine system (3%)   
PPAR signalling pathway (2%)   
K08751 Intestinal fatty acid-binding protein +2.06 
K08745 Solute carrier family 27 (fatty acid transporter) -1.50 
Insulin signalling pathway (1%)   
K07189 Protein phosphatase 1 regulatory subunit 3A -1.67 
Cell death and motility (2%)   
Apoptosis (1%)   
K04724 Programmed cell death 8 +1.51 
Regulation of actin cytoskeleton (1%)   
K05762 Radixin +1.75 
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Supplementary Table 4. Validation of microarray results by qPCR 936 
 
FFO vs WFO 
 
Microarray qPCR 
 
p FC p FC 
fads2d6 0.003 -2.11 0.021 -1.93 
fads2d5 0.002 -2.04 0.001 -1.38 
elovl2 >0.05 -1.33 >0.05 -1.41 
elovl5a >0.05 -1.35 0.004 -1.67 
elovl5b >0.05 -1.20 >0.05 -1.17 
 937 
Data shown are the fold-changes (FC) between expression levels in farmed salmon fed FO 938 
diet (FFO) and land-locked salmon fed RO diet (WFO) and p value (assessed by REST 939 
2009). fads2d6, delta-6 fatty acyl desaturase; fads2d5, delta-5 fatty acyl desaturase; elovl2, 940 
fatty acyl elongase 2; elovl5a, fatty acyl elongase 5 isoform a; elovl5b, fatty acyl elongase 941 
isoform b 942 
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